Dr Cheryl Keech | Executive Medical Director
PPD Vaccines

Dr Cheryl Keech, Executive Medical Director, PPD Vaccines

As therapeutic area head for vaccines, Cheryl Keech, M.D., Ph.D., leads strategy
for vaccine development programs from early phase through post-licensure. She
provides pharmaceutical development consulting for clients and PPD staff by
providing medical, scientific and product development expertise.
Dr. Keech joined PPD in 2016 with 20 years of experience in senior leadership
roles at an international health-related nonprofit organization and in the large
pharmaceutical industry, and as a board-certified practicing physician in internal
medicine and a doctorate in molecular biology. Her expertise and interest is
strongest in the development and delivery of vaccines across pediatrics and
adults, Phases I-IV, with a major focus on respiratory and maternal immunization
and ensuring the value proposition of vaccines can be accomplished during
program development. Her therapeutic expertise in infectious diseases includes
RSV, influenza, pneumococcus, pertussis, meningococcal, varicella/zoster,
vector-borne infections (malaria, Japanese encephalitis, dengue, zika and
chiukunguna), sexually transmitted diseases (HSV and HPV), rotavirus, as well
as childhood combination vaccines. She has been involved in working with
established manufacturers, developing country manufacturers and with the
biotech industry.
Beyond her therapeutic expertise, Dr. Keech has extensive global product
development knowledge across all phases of research and development,
across World Bank-defined country income levels and has worked directly
with WHO and GAVI on a number of vaccine approvals and global initiatives.
She is experienced with national regulatory needs, global endorsement/
recommendation processes and the value proposition requirements for
commercialization of new vaccine candidates.
Cheryl holds a Bachelor of Science in animal science from Michigan State
University, a Master of Science in reproductive physiology from Texas A&M
University, a doctorate in molecular biology and biochemistry from the division
of endocrinology at the University of Colorado Health Sciences Center, and a
medical degree from Indiana University Medical Center, where she completed
her medical residency in internal medicine. She has practiced internal medicine
and appreciates the concerns and issues at the physician and patient level.


DC Co-conference Day 2 April 4 @ 4:40

Operational considerations for global respiratory studies – Using seasonality to guide study execution

back to speakers